Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

Completed · Phase 2

Conditions studied: HIV Infections, H1N1 Influenza Virus

In brief

Children and people infected with HIV are particularly susceptible to influenza infections. This study testED the safety and effectiveness of a vaccine for the new H1N1 influenza virus in children and youth infected with HIV.

Key facts

Study ID
NCT00992836
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
155
Starts
2009-10-01
Expected to finish
2010-08-01
Last updated by the study team
2021-11-05

Who can join

Age: 4 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.